ArticleHealth science reports2026
Serum Uric Acid Levels and the Risk of Breast Cancer and Benign Breast Tumors: A Systematic Review and Meta-Analysis.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Serum uric acid (SUA) has been implicated in various pathological conditions, yet its association with breast pathology remains controversial. This study aimed to investigate the association between SUA levels and breast cancer (BC) and benign breast tumors (BBT) risk through systematic review and meta-analysis. Methods: A comprehensive search was conducted in PubMed, Web of Science, Embase, Cochrane Library, China National Knowledge Infrastructure (CNKI), Wanfang Data, Weipu Database, and China Biology Medicine disc (CBMdisc) from inception to July 31, 2024. Eligible studies included cross-sectional, case-control, and cohort studies investigating the relationship between BC, BBT, and SUA. Data extraction was independently performed by two reviewers. The methodological quality was assessed using the Newcastle-Ottawa Scale (NOS). STATA V 13.0 software was used for statistical analysis. Results: Sixteen studies (21,760 participants: 1037 BC, 220 BBT, 20,503 controls) were included. Overall, BC patients showed no significant SUA compared to controls (SMD = 0.05, 95% CI: -0.31 to 0.40, Conclusion: Elevated SUA levels are positively associated with the risk of BC and BBT in females. Although SUA may serve as a potential therapeutic target and diagnostic biomarker, these associations require further validation through prospective studies and randomized controlled trials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.